Search

everythinglearnresearchcommunity

for

Search:↓

Demographic and lifestyle factors significantly influence scalp diseases.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Vitamin D is crucial for skin health and managing skin diseases.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Detoxil effectively treats chronic skin conditions by improving liver detoxification and reducing symptoms.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Itchy scalp is common, linked to various conditions, and hard to treat effectively.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Sarcoidosis can cause scarring hair loss on the scalp, which is rare.

Korean patients with rosacea are more likely to have other health conditions.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.